Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics
![]() |
SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a large-scale Manufacturing Supply Agreement for...
Read more: Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics





